Introduction
Neurodegenerative diseases are a group of disorders in which nerve cells in the brain or spinal cord progressively lose structure and function, leading to declining movement, cognition, behaviour, or autonomic control. Examples include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
They are mostly age-associated but some have genetic onset in mid-life. Symptoms develop gradually and worsen over years, significantly affecting independence and caregiver burden.
No cure exists for most conditions, but medications, rehabilitation, deep brain stimulation (in selected Parkinson's cases), and supportive care can slow symptoms and improve quality of life.
This page explains common types, symptoms, causes, diagnosis, treatment approaches, prevention strategies, and when neurology referral is appropriate.
Overview
Global burden rising with aging populations. Each disease has distinct pathology—amyloid/tau in Alzheimer's, alpha-synuclein in Parkinson's, CAG repeat in Huntington's, motor neuron loss in ALS.
Early diagnosis allows planning, symptomatic therapy, and inclusion in clinical trials. Mimics include vitamin deficiencies, normal pressure hydrocephalus, and depression-related cognitive slowing.
- Progressive loss of neuron function over time
- Major types: Alzheimer's, Parkinson's, Huntington's, ALS, others
- Symptoms: memory loss, tremor, rigidity, weakness, behaviour change
- Some forms strongly genetic; most sporadic with age risk
- Diagnosis: history, exam, MRI, labs, sometimes genetic or CSF tests
- Treatment symptomatic; research on disease-modifying agents ongoing
- Rehabilitation, caregiver support, advance care planning vital
- Prevention strategies may reduce risk but cannot guarantee avoidance
What happens in the body
Abnormal protein aggregation, mitochondrial dysfunction, oxidative stress, and inflammation contribute to selective neuron death in disease-specific brain regions. In Alzheimer's, hippocampal and cortical neurons degenerate; in Parkinson's, dopaminergic neurons in substantia nigra are lost.
Genetic mutations (APP, PSEN, SNCA, HTT, C9orf72, etc.) trigger or accelerate pathology in familial forms.
- Protein misfolding and toxic aggregates in many diseases
- Synaptic loss precedes visible cell death on imaging
- Circuit disruption causes clinical symptoms by anatomy
- Spread along connected networks proposed in some models
- Inflammation and vascular factors modulate progression rate
Signs and symptoms
Symptoms depend on disease and affected brain regions:
- Memory loss, confusion, language difficulty (dementia syndromes)
- Tremor, slowness, stiffness, balance problems (Parkinsonism)
- Involuntary choreiform movements, mood change (Huntington's)
- Progressive weakness, fasciculations, dysarthria (ALS)
- Visual hallucinations and fluctuating cognition (Lewy body dementia)
- Personality change, apathy, depression across many conditions
- Swallowing difficulty and weight loss in advanced stages
- Autonomic symptoms: blood pressure swings, bladder dysfunction
Causes and risk factors
Mix of age, genetics, and environmental factors:
- Advancing age strongest risk for Alzheimer's and Parkinson's
- Inherited mutations in familial Alzheimer's, Huntington's, some ALS
- Head trauma association with chronic traumatic encephalopathy and Parkinson's risk
- Vascular disease contributing to mixed dementia
- Pesticide and toxin exposure linked to Parkinson's in some studies
- Not contagious; not caused by single lifestyle choice alone
Diagnosis and evaluation
Neurology evaluation with supportive tests:
- Detailed cognitive and motor examination
- Brain MRI to exclude stroke, tumor, hydrocephalus
- Laboratory tests: B12, thyroid, syphilis serology when indicated
- PET or CSF biomarkers for Alzheimer's in selected cases
- Genetic testing when familial pattern or young onset
- EMG for suspected motor neuron disease
- Differentiate depression, medication effects, delirium
Treatment and management
Symptom management and multidisciplinary support:
- Alzheimer's: cholinesterase inhibitors, memantine; new anti-amyloid antibodies in eligible early cases per guidelines
- Parkinson's: levodopa, dopamine agonists, MAO-B inhibitors; DBS for motor fluctuations
- Huntington's: tetrabenazine/deutetrabenazine for chorea; supportive psychiatry
- ALS: riluzole, edaravone where available; NIV, gastrostomy, multidisciplinary MND care
- Physiotherapy, occupational therapy, speech therapy
- Caregiver education, respite, legal and financial planning
- Clinical trials for disease-modifying therapies
Prevention, self-care, and lifestyle
Not every condition is fully preventable, but the steps below may lower risk or recurrence:
- Cardiovascular risk control may reduce vascular dementia contribution
- Regular exercise, social engagement, cognitively stimulating activities associated with lower dementia risk in observational studies
- Heart-healthy diet rich in vegetables, whole grains, omega-3 fats
- Head injury prevention in contact sports
- Cannot fully prevent genetic or sporadic neurodegeneration
Possible complications
Delay, missed care, or unsafe self-medication can raise the chance of complications in some cases:
- Loss of independence in ADLs and mobility
- Aspiration pneumonia from dysphagia
- Falls and fractures in Parkinson's and dementia
- Behavioral disturbance, wandering, caregiver burnout
- Respiratory failure in ALS
- Psychiatric comorbidity: depression, psychosis
When to see a doctor or seek emergency care
Seek prompt medical advice or emergency care if any of the following apply—it is safer not to wait and see:
- Progressive memory loss affecting daily function
- New tremor, slowness, or gait change
- Unexplained progressive weakness or speech change
- Family history of Huntington's with movement or mood symptoms
- Sudden cognitive change—exclude delirium and stroke urgently
Living with the condition
Early diagnosis allows advance directives and home adaptation. Support groups and respite care reduce caregiver strain. Maintain routine, safety modifications, and medication adherence under neurology follow-up.
Frequently asked questions
Are all neurodegenerative diseases the same?
No—each affects different neurons and has distinct symptoms, progression, and treatments.
Can exercise prevent Alzheimer's?
Exercise associates with lower risk but does not guarantee prevention.
Is dementia always Alzheimer's?
No—many causes including vascular, Lewy body, frontotemporal, and reversible conditions.
Important caution
This article is general health education, not neurology prescribing advice.
Progressive cognitive or motor symptoms require professional evaluation.
Treatment and genetic testing decisions should involve a qualified neurologist.